Page last updated: 2024-10-22

albendazole and Nephrosis, Lipoid

albendazole has been researched along with Nephrosis, Lipoid in 2 studies

Nephrosis, Lipoid: A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA.

Research Excerpts

ExcerptRelevanceReference
"The kidney biopsy revealed minimal change glomerulonephritis."2.41Minimal change glomerulonephritis associated with hydatid disease. ( Ben-Itzhak, O; Brook, G; Gelman, R; Green, J; Nakhoul, F, 2000)
"Strongyloidiasis is caused by a small intestinal nematode with a complex life cycle."1.34[Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: a case report]. ( Bono, L; Coglitore, M; Faraci, C; Giordano, S; Infurnari, L; Romano, A; Rotolo, U; Rubino, R; Scarlata, F; Tortorici, C, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rotolo, U1
Scarlata, F1
Giordano, S1
Tortorici, C1
Bono, L1
Coglitore, M1
Faraci, C1
Infurnari, L1
Rubino, R1
Romano, A1
Gelman, R1
Brook, G1
Green, J1
Ben-Itzhak, O1
Nakhoul, F1

Reviews

1 review available for albendazole and Nephrosis, Lipoid

ArticleYear
Minimal change glomerulonephritis associated with hydatid disease.
    Clinical nephrology, 2000, Volume: 53, Issue:2

    Topics: Albendazole; Anticestodal Agents; Biopsy; Echinococcosis, Hepatic; Humans; Immunologic Tests; Kidney

2000

Other Studies

1 other study available for albendazole and Nephrosis, Lipoid

ArticleYear
[Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: a case report].
    Le infezioni in medicina, 2007, Volume: 15, Issue:1

    Topics: Adult; Albendazole; Animals; Anthelmintics; Anti-Bacterial Agents; Bacteremia; Ecuador; Endemic Dise

2007